Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | LN-144 |
Trade Name | |
Synonyms | Lifileucel|LN144|LN 144 |
Drug Descriptions |
LN-144 (lifileucel) is a preparation of tumor infiltrating lymphocytes isolated and expanded from patient tumor tissue, which may demonstrate enhanced anti-tumor immune activity when re-introduced into patients (Journal of Clinical Oncology 35, no. 15_suppl (May 20 2017) 3045-3045). |
DrugClasses | |
CAS Registry Number | 2306267-74-1 |
NCIT ID | C120552 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cyclophosphamide + Fludarabine + LN-144 + Pembrolizumab | Cyclophosphamide Fludarabine LN-144 Pembrolizumab | 0 | 1 |
LN-144 | LN-144 | 0 | 4 |
LN-144 + Pembrolizumab | LN-144 Pembrolizumab | 0 | 1 |